TY - CHAP AU - Iliás, Ákos ED - Takács, István TI - Akut és krónikus gastrointestinalis vérzés T2 - Belgyógyászat 1 tantárgyi jegyzet PB - Semmelweis Kiadó CY - Budapest SN - 9789633316122 PY - 2024 SP - 241 EP - 246 PG - 6 UR - https://m2.mtmt.hu/api/publication/34817618 ID - 34817618 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Lontai, Livia AU - Elek, Lívia Priyanka AU - Balogh, Fruzsina AU - Angyal, Dorottya AU - Pajkossy, Péter AU - Gönczi, Lóránt AU - Lakatos, Péter László AU - Iliás, Ákos TI - Burden of Mental Health among Patients with Inflammatory Bowel Disease—A Cross-Sectional Study from a Tertiary IBD Center in Hungary JF - JOURNAL OF CLINICAL MEDICINE J2 - J CLIN MED VL - 13 PY - 2024 IS - 7 PG - 9 SN - 2077-0383 DO - 10.3390/jcm13072002 UR - https://m2.mtmt.hu/api/publication/34763005 ID - 34763005 N1 - Funding Agency and Grant Number: Semmelweis University, Department of Internal Medicine and Oncology Funding text: Publication of this paper was supported by the Semmelweis University, Department of Internal Medicine and Oncology. AB - Background: Inflammatory bowel diseases (IBDs) are chronic conditions that negatively affect the patient’s quality of life. With the spread of the biopsychosocial model, the role of mental health in the activity and course of inflammatory bowel disease is becoming more and more recognized. Our study aimed to assess the prevalence of anxiety and depression in IBD patients in our tertiary referral center and determine the predictive factors of these mental conditions. Methods: A total of 117 patients were included consecutively between 1 December 2021 and 28 February 2022. We used a questionnaire to gather demographic information, disease course, and IBD-specific symptoms. We assessed anxiety symptoms using the GAD-7 and depressive complaints using the PHQ-9 questionnaire. We evaluated disease activity using CDAI and pMayo scores. Results: Of the 117 patients (male/female: 63/54), 88 suffered from Crohn’s disease, and 29 were diagnosed with ulcerative colitis. Only 6 patients were taking medication for mood disorders, and 38 individuals sought mental support during their lifetime. A total of 15% of the population suffered from moderate–severe anxiety disorder, and 22% were affected by moderate–severe depression. The GAD-7 and PHQ9 values showed a significant correlation between the number of stools, bloody stools, abdominal pain, number of flare-ups, and CDAI scores. Conclusions: Our study confirmed that there is a high incidence of anxiety and depressive symptoms among IBD patients. Our results highlighted the symptoms that could be associated with mental disorders. It is important to assess the mental status of IBD patients to improve their quality of life. LA - English DB - MTMT ER - TY - JOUR AU - Gönczi, Lóránt AU - Lakatos, László AU - Iliás, Ákos AU - Lakatos, Péter László TI - Editorial: The prevalence and outcomes of perianal Crohn's disease across the treatment eras—Authors' reply JF - ALIMENTARY PHARMACOLOGY & THERAPEUTICS J2 - ALIMENT PHARM THER VL - 59 PY - 2024 IS - 5 SP - 715 EP - 716 PG - 2 SN - 0269-2813 DO - 10.1111/apt.17879 UR - https://m2.mtmt.hu/api/publication/34579597 ID - 34579597 N1 - Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary Department of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem, Hungary Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, QC, Canada Export Date: 17 March 2024 CODEN: APTHE Correspondence Address: Lakatos, P.L.; IBD Centre, 1650 Ave. Cedar, D16.173.1, Canada; email: peter.lakatos@mcgill.ca AB - This article is linked to Gonczi et al papers. To view these articles, visit https://doi.org/10.1111/apt.17836 and https://doi.org/10.1111/apt.17861 LA - English DB - MTMT ER - TY - JOUR AU - Barkai, László József AU - Gönczi, Lóránt AU - Farkas, Klaudia AU - Farkas, Bernadett AU - Molnár, Tamás AU - Szamosi, T AU - Schafer, E AU - Golovics, P AU - Juhasz, M AU - Patai, A AU - Vincze, A AU - Sarlos, P AU - Farkas, A AU - Dubravcsik, Z AU - Toth, T G AU - Miheller, P AU - Lakatos, Péter László AU - Iliás, Ákos TI - P661 Ustekinumab in Crohn’s disease: A three-year multicentre prospective study from Hungary - Assessing efficacy, drug sustainability, and safety JF - JOURNAL OF CROHNS & COLITIS J2 - J CROHNS COLITIS VL - 18 PY - 2024 IS - Supplement_1 SP - i1259 EP - i1259 PG - 1 SN - 1873-9946 DO - 10.1093/ecco-jcc/jjad212.0791 UR - https://m2.mtmt.hu/api/publication/34533252 ID - 34533252 LA - English DB - MTMT ER - TY - JOUR AU - Gönczi, Lóránt AU - Lakatos, László AU - Golovics, Petra A. AU - Angyal, Dorottya AU - Balogh, Fruzsina AU - Iliás, Ákos AU - Pandur, Tunde AU - David, Gyula AU - Erdelyi, Zsuzsanna AU - Szita, Istvan AU - Lakatos, Péter László TI - Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades JF - ALIMENTARY PHARMACOLOGY & THERAPEUTICS J2 - ALIMENT PHARM THER VL - 59 PY - 2024 IS - 5 SP - 656 EP - 665 PG - 10 SN - 0269-2813 DO - 10.1111/apt.17836 UR - https://m2.mtmt.hu/api/publication/34445434 ID - 34445434 N1 - Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary Department of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem, Hungary Department of Gastroenterology, Hungarian Defence Forces Medical Centre, Budapest, Hungary Department of Gastroenterology, Grof Eszterhazy Hospital, Papa, Hungary Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Canada Export Date: 20 January 2024 CODEN: APTHE Correspondence Address: Lakatos, P.L.; MUHC, 1650 Ave. Cedar, D16.173.1, Canada; email: peter.lakatos@mcgill.ca LA - English DB - MTMT ER - TY - JOUR AU - Lőrinczi, Csaba AU - Iliás, Ákos TI - A szénhidrátok és a gastrointestinalis rendszer JF - MAGYAR BELORVOSI ARCHIVUM J2 - MBA VL - 76 PY - 2023 IS - 5-6 SP - 226 EP - 231 PG - 6 SN - 0133-5464 DO - 10.59063/mba.2023.76.5-6.2 UR - https://m2.mtmt.hu/api/publication/34553170 ID - 34553170 AB - Napjainkban egyre elterjedtebb az úgynevezett „nyugati típusú” diéta, amelynek jellegzetessége a nagy mennyiségű zsír-, illetve szénhidráttartalom és a többszörösen feldolgozott élelmiszerek nagy aránya. Az emberi szervezet az evolúció során azonban nem ehhez a diétához adaptálódott, így az étrenddel bevitt jelentős kalória megterheli a testünket, köztük a gastrointestinalis rendszert és különböző betegségek kialakulásához vezethet. A legalapvetőbb zavar a bél mikrobiom megváltozása, amely a bél permeabilitásának fokozásán keresztül a mucosalis immunitás zavarát okozza. A közleményben a szerzők a különböző szénhidrátok útját mutatják be az emésztőrendszerben, illetve ezek kapcsolatát a bélben lezajló patológiás folyamatokkal. LA - Hungarian DB - MTMT ER - TY - JOUR AU - Lovász, Barbara Dorottya AU - Kecse, Éva Krisztina AU - Bak, Dominika AU - Iliás, Ákos AU - Svébis, Márk Márton AU - Gadó, Klára TI - A gyulladásos bélbetegségek társadalmi hatásai: a munkaképesség és az életminőség vizsgálata JF - ORVOSI HETILAP J2 - ORV HETIL VL - 164 PY - 2023 IS - 50 SP - 1974 EP - 1984 PG - 11 SN - 0030-6002 DO - 10.1556/650.2023.32917 UR - https://m2.mtmt.hu/api/publication/34441241 ID - 34441241 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Lorinczi, Csaba AU - Iliás, Ákos TI - Candidaoesophagitis mint indikátorbetegség JF - ORVOSI HETILAP J2 - ORV HETIL VL - 164 PY - 2023 IS - 22 SP - 878 EP - 880 PG - 3 SN - 0030-6002 DO - 10.1556/650.2023.32768 UR - https://m2.mtmt.hu/api/publication/34085449 ID - 34085449 AB - Esophageal candidiasis is the most common infectious disease of the esophagus. The diagnosis is based on gastros- copy, and in many cases, biopsy samples should be taken as well. If we do not know of any risk factors for an immu- nocompromised condition, it is a mutual responsibility to confirm or exclude any potential chronic disease in the background, thus not just the secondary complication but also the primary disease could be treated. Without this knowledge, in many cases, the correct diagnosis may be delayed for months or even years, which may risk the suc- cessful treatment. We present the case of a 58-year-old healthy woman without any chronic disease, who was referred to our clinic with dysphagia. Due to her complaints we performed a gastroscopy, upon which advanced esophageal candidiasis was diagnosed, hence she was started on oral systemic antifungal treatment. Although we could not ex- plore any risk factors, further investigations behind the immunocompromised condition revealed a positive immu- noserology test for HIV. The take-home message of our case is that in the case of esophageal candidiasis, the cause of immunosuppression must be searched for, of which HIV serology is crucial. Thanks to the prompt and correct diagnosis, we could start the suitable treatment of the underlying disease. LA - Hungarian DB - MTMT ER - TY - JOUR AU - Gönczi, Lóránt AU - Lakatos, László AU - Golovics, Petra A AU - Iliás, Ákos AU - Pandur, Tunde AU - David, Gyula AU - Erdelyi, Zsuzsanna AU - Szita, Istvan AU - Al Khoury, Alex AU - Lakatos, Péter László TI - Declining trends of reoperations and disease behavior progression in Crohn’s disease over different therapeutic eras – a prospective population-based study from western Hungary between 1977–2020, data from the Veszprem cohort JF - JOURNAL OF CROHNS & COLITIS J2 - J CROHNS COLITIS VL - 17 PY - 2023 IS - 12 SP - 1980 EP - 1987 PG - 8 SN - 1873-9946 DO - 10.1093/ecco-jcc/jjad117 UR - https://m2.mtmt.hu/api/publication/34055444 ID - 34055444 N1 - Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary Department of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem, Hungary Department of Gastroenterology, Hungarian Defence Forces Medical Centre, Budapest, Hungary Department of Gastroenterology, Grof Eszterhazy Hospital, Papa, Hungary Gastro Health, LLC-Care Center, Hollywood, FL, United States Division of Gastroenterology, McGill University Health Center, Montreal, QC, Canada Cited By :1 Export Date: 30 January 2024 Chemicals/CAS: azathioprine, 446-86-6, 55774-33-9; infliximab, 170277-31-3; Immunosuppressive Agents Tradenames: SPSS software v. 20.0 LA - English DB - MTMT ER - TY - JOUR AU - Bacsur, Péter AU - Iliás, Ákos AU - Resál, Tamás AU - Kata, Diána AU - Molnár, Tamás AU - Farkas, Klaudia TI - Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary JF - ALIMENTARY PHARMACOLOGY & THERAPEUTICS J2 - ALIMENT PHARM THER VL - 58 PY - 2023 IS - 2 SP - 262 EP - 263 PG - 2 SN - 0269-2813 DO - 10.1111/apt.17610 UR - https://m2.mtmt.hu/api/publication/34034445 ID - 34034445 LA - English DB - MTMT ER -